CLARIO Trademark

Trademark Overview

On Wednesday, November 3, 2021, a trademark application was filed for CLARIO with the United States Patent and Trademark Office. The USPTO has given the CLARIO trademark a serial number of 97107116. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, November 5, 2024. This trademark is owned by eResearchTechnology, Inc.. The CLARIO trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship

Data automation and collection service using proprietary software to evaluate, analyze and collect service data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
clario

General Information

Serial Number97107116
Word MarkCLARIO
Filing DateWednesday, November 3, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements

Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship
Goods and ServicesData automation and collection service using proprietary software to evaluate, analyze and collect service data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; none of the aforesaid services relating to the custom design and development of computer hardware and software except as relating to medical research or medical clinical trials; none of the foregoing for in vitro diagnostics, detection of contaminants, infectious disease surveillance, disease prevention and control, and/or antimicrobial stewardship

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameeResearchTechnology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103
Party NameeResearchTechnology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Trademark Events

Event DateEvent Description
Saturday, November 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 6, 2021NEW APPLICATION ENTERED
Saturday, November 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, March 18, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, August 12, 2022ASSIGNED TO EXAMINER
Monday, August 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 22, 2022NON-FINAL ACTION WRITTEN
Monday, August 22, 2022NON-FINAL ACTION E-MAILED
Monday, August 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 7, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, October 13, 2022ELECTRONIC RECORD REVIEW COMPLETE
Tuesday, November 29, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, October 25, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, November 25, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 29, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 29, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, November 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 20, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, May 4, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, May 22, 2023ASSIGNED TO PETITION STAFF
Tuesday, May 23, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, June 26, 2023OPPOSITION INSTITUTED NO. 999999
Monday, September 25, 2023OPPOSITION TERMINATED NO. 999999
Monday, September 25, 2023OPPOSITION DISMISSED NO. 999999
Monday, September 25, 2023TTAB RELEASE CASE TO TRADEMARKS
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 22, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 20, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, March 20, 2024SOU EXTENSION 1 FILED
Wednesday, March 20, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, March 20, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 16, 2024ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, April 17, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 17, 2024RESPONSE TO ITU OFFICE ACTION ENTERED
Monday, April 22, 2024DIVISIONAL PROCESSING COMPLETE
Monday, April 22, 2024SOU EXTENSION 1 GRANTED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2024CORRECTED NOA E-MAILED
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU EXTENSION 2 GRANTED
Tuesday, November 5, 2024SOU EXTENSION 2 FILED

Related Keywords

clario clinical trials management research medical providing business field disease information